Select Pharma Laboratories Ltd.
Select Pharma Laboratories Ltd.
#SC368899 • Active
Founded: 20/11/2009
Industries: Technical testing and analysis
Location: 3rd Floor 2 Semple Street, Edinburgh, EH3 8BL, Scotland
Financial Snapshot
Last accounts made up to 31 December 2023
Next accounts due 30 September 2025 (5 months)
Cash in Bank £6,000
↑ 500%
Total Liabilities £0.92m
↓ -13%
Employees 2
↓ -33%
Directors
Name | Role | Appointed ↓ | Nationality | Age |
|---|---|---|---|---|
| Amanda Louise Barlow | Finance Director | 27/09/2023 | British | 51 years |
| Jay Charles Lecoque | Executive Chairman | 27/04/2017 | American | 62 years |
Role:
Finance Director
Appointed:
27/09/2023
Nationality:
British
Age:
51 years
Role:
Executive Chairman
Appointed:
27/04/2017
Nationality:
American
Age:
62 years
People with Significant Control
| Name | Nature of Control | Notified On | Nationality |
|---|---|---|---|
| Source Bioscience Limited | Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent, Right To Appoint And Remove Directors | 20/11/2016 | United Kingdom |
Nature of Control:
Ownership Of Shares 75 To 100 Percent, Voting Rights 75 To 100 Percent, Right To Appoint And Remove Directors
Notified On:
20/11/2016
Nationality:
United Kingdom
Financial Accounts
| Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|
| Income Statement | |||
| Turnover | |||
| Export Revenue | |||
| Sales | |||
| Other Operating Income | |||
| Other Operating Items | |||
| Cost of Sales | |||
| Raw Materials & Consumables | |||
| Gross Profit | |||
| Admin Expenses | |||
| Other Operating Charges | |||
| Depreciation | |||
| R&D Expenses | |||
| Operating Profit | |||
| EBITDA | |||
| Financial Revenue | |||
| Financial Expenses | |||
| Financial Profit/Loss | |||
| Interest Paid | |||
| Extraordinary Revenue | |||
| Extraordinary Expenses | |||
| Net Extraordinary Items | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Retained Profit | |||
| Balance Sheet | |||
| Non-Current Assets | |||
| Intangible Assets | |||
| Tangible Fixed Assets | |||
| Other Non-Current Assets | |||
| Current Assets | |||
| Stock | |||
| Debtors | |||
| Cash in Hand | |||
| Other Current Assets | |||
| Called Up Share Capital | |||
| P&L Account Reserve | |||
| Shareholder Funds | |||
| Other Shareholder Funds | |||
| Provisions | |||
| Long Term Debt | |||
| Creditors (> 1 year) | |||
| Other Non-Current Liabilities | |||
| Short Term Debt | |||
| Creditors | |||
| Creditors (< 1 year) | |||
| Other Current Liabilities | |||
| Key Metrics | |||
| Net Assets | |||
| Net Current Assets | |||
| Total Assets Less Current Liabilities | |||
| Working Capital | |||
| Enterprise Value | |||
| Added Value | |||
| Cashflow Before D&A | |||
| Other Information | |||
| Staff Costs | |||
| Number of Employees | |||
Charges
3 charges registered
Barclays Bank PLC Satisfied
Created 24/03/2016All properties (as defined in the instrument) presently owned or acquired in the future by the borro...
#SC3688990002 Negative Pledge
Barclays Bank PLC Satisfied
Created 24/03/2016#SC3688990003 Negative Pledge
Properties
No property information available
Grants
No grant information available
Government Council Contracts Beta
No council contracts found
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 20/11/2024 | Confirmation Statement | Confirmation Statement With Updates | View (4 pages) |
| 07/10/2024 | Accounts | Accounts With Accounts Type Small | View (13 pages) |
| 23/11/2023 | Confirmation Statement | Confirmation Statement With Updates | View (4 pages) |
| 02/10/2023 | Officers | Appoint Person Director Company With Name Date | View (2 pages) |
| 02/10/2023 | Officers | Termination Director Company With Name Termination Date | View (1 page) |
| 06/06/2023 | Accounts | Accounts With Accounts Type Small | View (14 pages) |
| 20/11/2022 | Confirmation Statement | Confirmation Statement With Updates | View (4 pages) |